High Court Passes On Galderma's Acne Gel Patent Fight
The U.S. Supreme Court on Monday declined to hear Galderma Laboratories LP's challenge to a Federal Circuit finding that claims of its acne treatment patents asserted against Tolmar Inc. were invalid...To view the full article, register now.
Already a subscriber? Click here to view full article